Doctors are implanting dopamine-producing stem cells into patients with Parkinson's disease in a groundbreaking clinical trial[1][2]. The study tests whether specially modified stem cells can restore the brain's own production of dopamine[1][2]. Parkinson's disease is caused by the gradual loss of dopamine-producing cells, leading to tremors, stiffness, and slowed movement[1][2]. Researchers implant cells grown in the laboratory directly into the movement center of the brain to replace the lost cells[1][2]. Two small clinical trials published in the journal Nature bring promising news and show the first steps towards replacing dead nerve cells with stem cell injections[1][2]. Stem cell-derived cells develop into specialized dopamine-producing neurons[1][2]. The disease affects more than 8 million people worldwide[1][2]. The results confirm that dopaminergic progenitors from stem cells can safely affect symptoms[1][2].